Company profileMixed portfolio#732 of 1,318 in Pakistan✓ No DRAP alerts

Ethical Laboratories Pak (Pvt) Ltd.

Mixed portfolio · 11 pharmaceutical brands of 12 registrations

Ranked #7 of 23 companies in Eye Conditions

12 registered products 11 pharmaceutical brands 22 distinct molecules 0 DRAP alerts
Part of this company's portfolio (“Eye”) is registered under a broad DRAP category rather than distinct molecules, so the molecule count understates its true range.

Company overview

12
registered products
11
pharmaceutical brands
22
distinct molecules
6
therapeutic classes
0
DRAP alerts

Ethical Laboratories Pak (Pvt) Ltd. is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 12 product registrations across 22 distinct molecules. Its portfolio is concentrated in Eye Conditions and Anti-Infective, Ophthalmologicals. It has no DRAP recall, shortage or safety notices on record.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Products by Ethical

9 products matched in our catalogue — each with its observed price and DRAP approved ceiling.

Unmapped-Medicine 1

Price ceiling age

DRAP sets a maximum price per registration and revises it only on application. In a market with high inflation, an old ceiling erodes margin in real terms.

1
ceilings with an approval date
0
not revised in 2+ years
2026
oldest approval year
20261

Top molecules by brand count

Eye7 brands
Acetazolamide ...... 250 Mg1 brand

Therapeutic classes

Eye Conditions · 10Anti-Infective, Ophthalmologicals · 1Antiglaucoma Preparations And Miotics · 1Unmapped-Medicine · 1Corticosteroids, Systemic Use · 1Hormone Regulators · 1

Conditions treated

Glaucoma/Mydriasis · 4Allergy/Infections · 3Dry Eye/Allergy · 2Hormonal Therapy · 1PAIN · 1

Price band (DRAP official ceilings)

Registered products priced by source
DRAP-official5 products · Rs 248.66 – Rs 3,314.95
DVAGO3 products · Rs 96 – Rs 225.12
Servaid14 products · Rs 36.53 – Rs 2,110
Median across source: Rs 141.92

Regulatory record

No DRAP alerts on record

No recalls, shortage notices or safety alerts involving this company’s products appear in the DRAP alert feed we track. Median across all 1,318 mapped companies is zero — 1,165 of them also have a clean sheet.

Competitive set

Companies whose registered portfolio overlaps most with this one.

Portfolio whitespace

Molecules the closest competitors have registered and this company has not — the starting point for a launch shortlist.

REMINGTON PHARMACEUTICAL INDUSTRIES (PVT) LTD. holds 61 molecules not in this portfolio
AcetazolamideAcyclovirAmlodipineAmoxicillinAmoxycillin BaseArtemether
ETHICAL LABORATORIES PRIVATE LIMITED holds 22 molecules not in this portfolio
AcetazolamideAscorbic AcidAtropineAzithromycinAzo CapsuleAzo Suspension
INNVOTEK PHARMACEUTICALS holds 41 molecules not in this portfolio
AcetazolamideAcyclovirArtemetherAscorbic AcidAzithromycinBisoprolol

Get the full profile for Ethical

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included

Company data as of 2026-07-30. Brand and molecule counts from the DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.